Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Indian J Psychiatry ; 57(2): 162-4, 2015.
Article in English | MEDLINE | ID: mdl-26124522

ABSTRACT

CONTEXT: This article aims at demonstrating the effectiveness of day care centers in Indian setting. This is to provide impetus for an innovative approach in psychiatric practice in India. AIMS: The aim was to narrate the experiences of a day care center being practiced in India. SETTINGS AND DESIGN: The study provides the experiences gained in a day care center at Lucknow. The center was started in a hired building with a minimum of staff. The cost of the program is around 30,000/months. SUBJECTS AND METHODS: The day care center has been run for nearly 5 years. During this period, 95 clients visited the center and 69 enrolled in the day care. Nearly 35 continued and 34 dropped out due to various reasons. STATISTICAL ANALYSIS: Descriptive study. RESULTS: There were 49 patients suffering from schizophrenia, 11 from affective disorders, and 9 patients were clubbed in the miscellaneous group. The miscellaneous group consisted of pervasive developmental disorders, slow learners, obsessive compulsive disorders (OCD) and borderline subnormality with psychosis. Most patients had a long duration of illness. The patients of schizophrenia continued in the program more often than other group. Nearly 50% of patients have obtained jobs. The exposure to day care improved the patient's social and occupational behavior. The core symptoms did not change substantially. The families were greatly empowered, and they developed a positive attitude toward illness. CONCLUSIONS: Of the 59 patients who joined the day care program 35 could continue regularly. Among these patients, nearly 50% could take up jobs. Social and occupational behaviors improved remarkably. The families were empowered, and they developed a positive attitude toward mental illness. Such programs can be improvised with minimal costs and can be value addition in psychiatric practice. We need to develop indigenous know-how for such programs. This is a preliminary communication.

2.
Cell Death Dis ; 1: e67, 2010.
Article in English | MEDLINE | ID: mdl-21197417

ABSTRACT

Pegylated Interferon-α2b (pIFN-α) is an integral part of the drug regimen currently employed against melanoma. Interferon Regulatory Factor-1 (IRF-1) plays an important role in the transcriptional regulation of the IFN response, cell cycle and apoptosis. We have studied pIFN-α induced responses when combined with the chemotherapy agent, vinblastine in tumor and endothelial cell lines and the connection to IRF-1 signaling. Levels of IRF-1/IRF-2 protein expression were found to be decreased in tumor versus normal tissues. pIFN-α induced IRF-1 signaling in human melanoma (M14) and endothelial (EA.hy926) cells and enhanced cell death when combined with vinblastine. Upon combined IFN-α and vinblastine treatment, p21 expression, PARP cleavage and activated Bak levels were increased in M14 cells. An increase in p21 and cyclin D1 expression occurred in EA.hy926 cells after 6 h of treatment with pIFN-α which dissipated by 24 h. This biphasic response, characteristic of cellular senescence, was more pronounced upon combined treatment. Exposure of the EA.hy926 cells to pIFN-α was associated with an enlarged, multinucleated, ß-galactosidase-positive senescent phenotype. The overall therapeutic mechanism of IFN-α combined with chemotherapy may be due to both direct tumor cell death via IRF-1 signaling and by premature senescence of endothelial cells and subsequent effects on angiogenesis in the tumor microenvironment.


Subject(s)
Cellular Senescence , Endothelial Cells/pathology , Interferon Regulatory Factor-2/metabolism , Interferon-alpha/therapeutic use , Melanoma/drug therapy , Polyethylene Glycols/therapeutic use , Signal Transduction , Blotting, Western , Cell Death/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cellular Senescence/drug effects , Drug Screening Assays, Antitumor , Drug Synergism , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Humans , Interferon Regulatory Factor-1/metabolism , Interferon alpha-2 , Interferon-alpha/pharmacology , Phenotype , Polyethylene Glycols/pharmacology , Recombinant Proteins , Signal Transduction/drug effects , Vinblastine/pharmacology
3.
Mol Cell Biochem ; 223(1-2): 71-80, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11681724

ABSTRACT

Understanding the response of tumors to ionizing radiation might potentially lead to improvement in tumor control and patient morbidity. Since the antioxidant status is likely to be linked to radioresponse, its modulation needs to be examined. Therefore, Swiss albino male mice (7-8 weeks old) with Ehrlich solid tumors were irradiated with different doses of gamma rays (0-9 Gy) at a dose rate of 0.0153 Gy/s; and enzymes involved in antioxidant functions were determined in the tumors. Radiation effects in terms of oxidative damage, LDH, nitric oxide and DNA fragmentation were also examined. In tumors, the specific activity of SOD was increased with dose but declined 6 Gy onwards. GST, DTD and GSH showed an almost progressive increase. These enhanced activities might have resulted from the increased protein expression. This possibility was supported by the Western Blot analysis for GST protein. These changes might be closely linked to the radiation-induced oxidative stress as reflected by the enhanced levels of peroxidative damage, DNA fragmentation, LDH activity and nitric oxide levels. These findings may have relevance to radiation therapy of cancer as the elevated antioxidant status of irradiated tumors is likely to limit the effectiveness of radiation dose and adversely affect the therapeutic gain.


Subject(s)
Carcinoma, Ehrlich Tumor/metabolism , Gamma Rays , Oxidative Stress , Animals , Carcinoma, Ehrlich Tumor/enzymology , Catalase/metabolism , DNA Fragmentation , Free Radical Scavengers/metabolism , Glutathione Transferase/metabolism , Humans , L-Lactate Dehydrogenase/metabolism , Lactoylglutathione Lyase/metabolism , Lipid Peroxidation , Male , Mice , NAD(P)H Dehydrogenase (Quinone)/metabolism , Neoplasm Transplantation , Nitric Oxide/metabolism , Regression Analysis , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
4.
Indian J Med Res ; 99: 223-6, 1994 May.
Article in English | MEDLINE | ID: mdl-7927580

ABSTRACT

Open neural tube defects (NTD) in babies, occurring over a 10 yr period (1982-91), in four major maternity hospitals of Lucknow, were identified to analyse the incidence of this disorder. The overall incidence of NTD was found to be 3.9/1000. It was significantly higher in the teaching hospital compared to non-teaching hospitals. But there was no significant difference in the incidence of NTD between the Government and Private hospitals. During the decade (1982-91) under study there was no decline in NTD births. These data could serve as base-line for the incidence of NTD in north India, as NTD is expected to decline with the introduction of folic acid for the prevention of NTD.


Subject(s)
Neural Tube Defects/epidemiology , Humans , Incidence , India/epidemiology , Retrospective Studies
5.
Am J Med Genet ; 43(6): 949-53, 1992 Aug 01.
Article in English | MEDLINE | ID: mdl-1415345

ABSTRACT

We present 2 unrelated fetuses with manifestations of both the hydrolethalus syndrome and the short rib-polydactyly syndrome, type Majewski. It is proposed that cases of hydrolethalus syndrome with short limbs constitute a separate type of lethal osteochondrodysplasia mimicking short rib-polydactyly syndromes.


Subject(s)
Hydrocephalus/complications , Short Rib-Polydactyly Syndrome/complications , Adult , Female , Fetus/pathology , Humans , Hydrocephalus/genetics , Hydrocephalus/pathology , Osteochondrodysplasias/genetics , Osteochondrodysplasias/pathology , Phenotype , Pregnancy , Short Rib-Polydactyly Syndrome/genetics , Short Rib-Polydactyly Syndrome/pathology , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL